Anders Österborg

5.4k total citations
78 papers, 3.4k citations indexed

About

Anders Österborg is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Anders Österborg has authored 78 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 34 papers in Genetics and 33 papers in Hematology. Recurrent topics in Anders Österborg's work include Chronic Lymphocytic Leukemia Research (26 papers), Multiple Myeloma Research and Treatments (17 papers) and Lymphoma Diagnosis and Treatment (17 papers). Anders Österborg is often cited by papers focused on Chronic Lymphocytic Leukemia Research (26 papers), Multiple Myeloma Research and Treatments (17 papers) and Lymphoma Diagnosis and Treatment (17 papers). Anders Österborg collaborates with scholars based in Sweden, United States and Iran. Anders Österborg's co-authors include Håkan Mellstedt, Donald Bunjes, Y Bastion, Martin J.S. Dyer, Gerassimos A. Pangalis, Daniel Catovsky, Jeanette Lundin, Susanne Bergenbrant, Hodjattallah Rabbani and Helena Jernberg‐Wiklund and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Anders Österborg

76 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Österborg Sweden	28	1.3k	1.2k	1.0k	994	986	78	3.4k
Kazimierz Kuliczkowski Poland	29	1.2k 0.9×	978 0.8×	1.2k 1.2×	1.1k 1.1×	794 0.8×	202	3.5k
G.J. Ossenkoppele Netherlands	34	1.6k 1.2×	607 0.5×	1.1k 1.1×	677 0.7×	812 0.8×	84	3.3k
Marı́a Dolores Caballero Spain	32	1.1k 0.9×	657 0.5×	1.2k 1.2×	586 0.6×	1.4k 1.4×	74	2.8k
Julio Delgado Spain	35	1.1k 0.9×	939 0.8×	1.0k 1.0×	1.6k 1.6×	1.3k 1.4×	195	3.6k
J Garcı́a-Conde Spain	35	984 0.8×	596 0.5×	2.0k 2.0×	792 0.8×	1.1k 1.1×	104	3.9k
Gerassimos A. Pangalis Greece	34	1.1k 0.8×	1.2k 1.0×	1.3k 1.3×	2.4k 2.4×	2.6k 2.6×	174	4.7k
Samantha Jaglowski United States	24	992 0.8×	896 0.7×	940 0.9×	1.5k 1.5×	1.2k 1.2×	152	2.9k
Hyeoung‐Joon Kim South Korea	29	1.4k 1.1×	957 0.8×	909 0.9×	524 0.5×	436 0.4×	213	3.0k
Terence Rooney United States	28	1.4k 1.1×	806 0.7×	932 0.9×	857 0.9×	398 0.4×	53	3.9k
Yago Nieto United States	34	1.9k 1.4×	609 0.5×	1.7k 1.7×	644 0.6×	594 0.6×	242	4.0k

Countries citing papers authored by Anders Österborg

Since Specialization

Citations

This map shows the geographic impact of Anders Österborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Österborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Österborg more than expected).

Fields of papers citing papers by Anders Österborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Österborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Österborg. The network helps show where Anders Österborg may publish in the future.

Co-authorship network of co-authors of Anders Österborg

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Österborg. A scholar is included among the top collaborators of Anders Österborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Österborg. Anders Österborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Björkholm, Magnus, et al.. (2025). Targeting Tumor Microenvironment Interactions in Chronic Lymphocytic Leukemia Using Leukotriene Inhibitors. International Journal of Molecular Sciences. 26(5). 2209–2209.

Kokhaei, Parviz, Ali Moshfegh, Jeanette Lundin, et al.. (2024). A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL). Cancers. 16(22). 3821–3821. 3 indexed citations

Kahn, Fredrik, Åsa Nilsdotter‐Augustinsson, Mats Fredrikson, et al.. (2024). Inborn errors of immunity are associated with increased COVID-19–related hospitalization and intensive care compared to the general population. Journal of Allergy and Clinical Immunology. 155(2). 387–397.e6. 2 indexed citations

Aapro, Matti, Yves Béguin, Carsten Bokemeyer, et al.. (2017). Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Annals of Oncology. 29(Suppl 4). iv96–iv110. 173 indexed citations

Jaing, Crystal, James B. Thissen, Shea N. Gardner, et al.. (2016). Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncology Letters. 12(4). 2782–2788. 6 indexed citations

Khan, Abdul Salam, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2016). Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. Tumor Biology. 37(9). 11947–11957. 26 indexed citations

Palma, Marzia, Anton Parker, Mohammad Hojjat‐Farsangi, et al.. (2013). Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia. Experimental Hematology. 41(7). 615–626. 13 indexed citations

Kharaziha, Pedram, Hendrik De Raeve, Qiao Li, et al.. (2012). Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro , Ex Vivo , and In Vivo in the 5T33MM Mouse Model. Cancer Research. 72(20). 5348–5362. 42 indexed citations

d’Amore, Francesco, Thomas Relander, Grete F. Lauritzsen, et al.. (2012). Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01. Journal of Clinical Oncology. 30(25). 3093–3099. 386 indexed citations

10.

Lemaire, Miguel, Prasoon Agarwal, Eline Menu, et al.. (2012). The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin. Clinical Cancer Research. 18(8). 2230–2239. 13 indexed citations

11.

d’Amore, Francesco, Thomas Relander, Esa Jantunen, et al.. (2009). Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral t-cell lymphomas (PTCLS) - overall and subtype-specific results of a phase II study from the nordic lymphoma group. Lund University Publications (Lund University). 20 indexed citations

12.

Adamson, Lars, Marzia Palma, A Choudhury, et al.. (2009). Generation of a Dendritic Cell‐based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large‐scale Production. Scandinavian Journal of Immunology. 69(6). 529–536. 13 indexed citations

13.

Borg, Sixten, Anna Glenngård, Anders Österborg, & Ulf Persson. (2008). The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: A Markov model. Acta Oncologica. 47(6). 1009–1017. 9 indexed citations

14.

Jeddi‐Tehrani, Mahmood, Claes Karlsson, Jeanette Lundin, et al.. (2006). Reconstitution of the T‐cell repertoire following treatment with alemtuzumab (anti‐CD52 monoclonal antibody) in patients with B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 135(4). 475–485. 17 indexed citations

15.

Lundin, Jeanette, Anna Porwit‐MacDonald, Eva Rossmann, et al.. (2004). Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. Leukemia. 18(3). 484–490. 91 indexed citations

16.

Lundin, Jeanette, Eva Kimby, Magnus Björkholm, et al.. (2001). Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).. Blood. 98. 4 indexed citations

17.

Hedenus, Michael, et al.. (2000). A randomized, blinded, placebo-controlled, phase II, dose-finding study of ARANESP (TM) in patients with lymphoproliferative malignancies.. Blood. 96(11). 15516. 4 indexed citations

18.

Österborg, Anders, et al.. (1995). Idiotype‐specific T cells in multiple myeloma stage I: an evaluation by four different functional tests. British Journal of Haematology. 89(1). 110–116. 57 indexed citations

19.

Österborg, Anders, Maria G. Masucci, Susanne Bergenbrant, et al.. (1991). Generation of T cell clones binding F(ab′)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy. Cancer Immunology Immunotherapy. 34(3). 157–162. 22 indexed citations

20.

Eng, Hubert, Ann Kari Lefvert, Håkan Mellstedt, & Anders Österborg. (1987). Human monoclonal immunoglobulins that bind the human acetylcholine receptor. European Journal of Immunology. 17(12). 1867–1869. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact